AlphaMark Advisors’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,863
Closed -$300K 613
2024
Q3
$300K Sell
2,863
-154
-5% -$18K 0.1% 190
2024
Q2
$429K Buy
3,017
+670
+29% +$77.2K 0.15% 87
2024
Q1
$262K Buy
+2,347
New +$280K 0.09% 202

Other funds holding ACLS

AlphaMark Advisors's ACLS Position: Q4 2024 in Review

AlphaMark Advisors sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 2,863 shares — an estimated $300K sold.

AlphaMark Advisors first reported a position in ACLS in Q1 2024 and held it in 3 quarters. The position peaked at $429K in Q2 2024. 322 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • AlphaMark Advisors reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 2,863 Axcelis shares in Q4 2024, an estimated $300K.
  • AlphaMark Advisors first reported a position in Axcelis in Q1 2024 and held it in 3 quarters.
  • AlphaMark Advisors's Axcelis position peaked at $429K in Q2 2024.
  • 322 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on AlphaMark Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.